{
  "id": 1541560,
  "title": "XPH vs PJP: Which Pharma ETF Offers Better Value",
  "url": "https://urgent.news/2026/08/17/xph-vs-pjp-which-pharma-etf-offers-better-value-1541560",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-17T18:14:01.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/xph-vs-pjp-which-pharma-etf-offers-better-value"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsThe State Street SPDR S&P Pharmaceuticals ETF offers a significantly lower expense ratio of 0.35% compared to the Invesco Pharmaceuticals ETF.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "XPH vs PJP: Which Pharma ETF Offers Better Value",
        "url": "https://urgent.news/2026/08/17/xph-vs-pjp-which-pharma-etf-offers-better-value",
        "published": "2026-08-17T17:54:01.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}